Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis

Amplification or mutation of the Her2 oncoantigen in human mammary glands leads to the development of an aggressive breast carcinoma. Several features of this breast carcinoma are reproduced in mammary carcinomas that spontaneously arise in female transgenic mice bearing the activated rat Her2 oncog...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Marco Macagno, Silvio Bandini, Elisabetta Bolli, Amanda Bello, Federica Riccardo, Giuseppina Barutello, Irene Fiore Merighi, Guido Forni, Alessia Lamolinara, Francesco Del Pizzo, Manuela Iezzi, Federica Cavallo, Laura Conti, Elena Quaglino
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-01-01
Colecção:	Biomedicines
Assuntos:	anti-Her2 antibodies ADCC CDC CDCC Her2 mammary cancer
Acesso em linha:	https://www.mdpi.com/2227-9059/10/2/230
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!